Repligen (RGEN) Enterprise Value (2010 - 2026)

Repligen (RGEN) has 17 years of Enterprise Value data on file, last reported at -$986.4 million in Q1 2026.

• On a quarterly basis, Enterprise Value fell 41.48% year-over-year to -$986.4 million in Q1 2026; TTM through Mar 2026 was -$986.4 million, a 41.48% decrease from a year earlier, with the FY2025 full-year figure at -$969.2 million, down 27.98% from the prior year.
• Enterprise Value for Q1 2026 stood at -$986.4 million, down from -$969.2 million in the prior quarter.
• Over the last five years, Enterprise Value for RGEN reached as high as -$573.4 million in Q3 2022 and fell as low as -$986.4 million in Q1 2026.
• Historically, Enterprise Value has averaged -$719.0 million across 5 years, with a median of -$708.9 million in 2025.
• Across the five-year window, Enterprise Value advanced 18.77% in 2022 and sank 41.48% in 2026, its largest moves.
• Year by year, Enterprise Value stood at -$623.8 million in 2022, then dropped by 20.45% to -$751.3 million in 2023, then slipped by 0.8% to -$757.4 million in 2024, then slipped by 27.98% to -$969.2 million in 2025, then declined by 1.77% to -$986.4 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$986.4 million in Q1 2026, -$969.2 million in Q4 2025, and -$748.7 million in Q3 2025.